Skip to content
  • Home
  • Company
    • About Us
    • Departments
    • Message From MD
  • Product
    • General
    • Hormones
    • Urology
    • Steroids
  • Media
    • Insights
    • Blogs
    • Gallery
  • Careers
  • Contact Us
Menu
Home / General / Osmotic Laxative / EVALAX
General

EVALAX

EVALAX contains lactulose solution. It belongs to the class of hyper-osmotic agent that has laxative action. It produces increased osmotic pressure within colon and acidifies its contents, resulting in increased stool water content and stool softening. It also causes migration of ammonia from blood into colon, where it is converted to ammonium ion and expelled through laxative action.

QR Code

General Info

Generic Name:

Lactulose

Therapeutic Category:

Osmotic Laxatives

Pharmacological Class:

Colonic Acidifier

Composition:

Lactulose 100/200 ml

Each 15 ml consists of Lactulose concentrate USP equivalent to Lactulose 10 gm

Composition:

B

Presentation:

Available in 100 ml and 200 ml bottles, each with a measuring cap

Mechanism of Action:

FOR CONSTIPATION

  • Lactulose passes unabsorbed down to large intestine.
  • Colonic bacteria convert lactulose to lactic acid, acetic and formic acid.
  • Increases the osmotic effect in the intestinal lumen.
  • Retains water and fluid.
  • Increases bowel volume content.
  • Thus, causes easy evacuation
FOR HEPATIC ENCEPHALOPATHY*:

Also, Lactulose causes a decrease in blood ammonia concentration and reduces the degree of portal-systemic encephalopathy. These actions are considered to be results of the following:

  • Bacterial degradation of Lactulose in the colon acidifies the colonic contents.
  • This acidification of colonic contents results in the retention of ammonia in the colon as the ammonium ion.
    Since the colonic contents are more acidic than the blood, ammonia can be expected to migrate from the blood into the colon to form the ammonium ion. The acid colonic contents convert (Ammonia) NH3 to the ammonium ion (NH4)+, trapping it and preventing its absorption.
Indications:
  • Constipation
  • Prevention & treatment of portal -systemic encephalopathy
  • Acidification of the colon contents attracts ammonia from the bloodstream, assisting stool excretion; helpful in liver failure when ammonia cannot be detoxified
Dosage:

Route of administration: Oral

Constipation

Adults: 15 to 30 mL (10 to 20 gm lactulose) daily; may increase to 60 mL/day.

Adjust dosage to produce 2 to 3 soft stools/day.

Hourly doses of 30 to 45 mL may be used for rapid laxation initially; reduce to recommended daily dose.

Portal-systemic encephalopathy

Adults: 30 to 45 ml, 3 to 4 times daily.

Pharmacokinetics:

Absorption: Poorly absorbed in gastrointestinal tract

Metabolism and Excretion: Absorbed lactulose is excreted unchanged in the urine. Unabsorbed lactulose is metabolized by colonic bacteria to lactic, acetic, and formic acids.

Half-life: 1.7 – 2 hours

Adverse Effects:
  • Belching*
  • Gas
  • Stomach cramp
  • Distention
  • Flatulence*
  • Diarrhea
Contraindications:

EVALAX is contraindicated in the following populations and situations:

Use in patients who require low-galactose diet.

Drug Interactions:
  • Anticoagulant effect of coumarins possibly enhanced by lactulose

Related Products

MECOBAL
  • Diabetic & peripheral neuropathy
  • Vitamin B12 deficiency & megaloblastic anemia
  • Bell’s palsy
  • Post-gastrectomy/ileal resection prophylaxis
  • Hyperhomocysteinemia & nerve support conditions

General

MECOBAL

OMIRA
  • GERD & reflux esophagitis
  • NSAID-induced gastritis
  • Functional dyspepsia
  • Peptic ulcer disease
  • H. pylori (combination therapy)

General

OMIRA

COFSY- BM
  • Bronchial asthma
  • Chronic bronchitis
  • COPD with mucus
  • Productive cough with bronchospasm
  • Pediatric cough with wheezing

Anti-Tussive

COFSY- BM

WELFEX
  • Allergic rhinitis (hay fever)
  • Chronic urticaria (hives)
  • Sneezing & runny nose
  • Itchy, watery eyes
  • Nasal & throat itching

Anti-Allergic

WELFEX

OHM Insights

View Detail

OHM INSIGHT 24th issue

View Detail

OHM INSIGHT 23nd Issue

View Detail

OHM INSIGHTS- 22th Issue

View Detail

OHM INSIGHT 21st ISSUE

OPL believes in developing medicines and products that are cost-effective as well are capable of providing high quality care to improve the health of the patients.

Quick Links
  • About Us
  • Contact Us
  • Products
  • Dealer Locator
  • Blogs
  • Our Team
  • Career
Product Category
  • General
  • Urology
  • Steroids
  • Hormones
Corporate Office
(+977) 4110791, 01-4110761
info@opl.com.np
Babu Ram Acharya Marg, Sinamangal, Kathmandu
Factory Office
(+977) 4110791, 01-4110761
info@opl.com.np
Tathali-09, Bhaktapur

Copyright 2026 OHM Pharmaceuticals Lab Pvt. Ltd. All Rights Reserved

Website Designed & Developed by Theme Nepal